Member support:
1300 854 838
Report Incident
Login
Join PDL

PDL guidance on the AstraZeneca COVID-19 vaccine

  • Written by: Steph Atmore
National
Disclaimer: This article was published in 2021 and reflects the information available at that time.
  The PDL Professional Officers have received several calls relating to the administration of the AstraZeneca (AZ) vaccine in patients below 60 years of age. Whilst the ATAGI advice regarding age ranges for AZ vaccine has not changed, recent Commonwealth government announcements have reiterated that healthcare practitioners, including pharmacists, can, with informed consent, administer the AstraZeneca vaccine to patients under the age of 60 years in certain circumstances. PDL has previously confirmed to all members that the PDL Master Policy provides cover for COVID-19 vaccinatio…

Member only access

This content is available to PDL members only.
To continue reading please log in to the member portal or join PDL today.

Login
Join PDL
Share this article

Related Practice Alerts

Staying vaccination-ready
26 March 2026
NationalProfessional activitiesVaccinationPractice support, tips and tools
Learn more
What pharmacists need to know about the new intranasal flu vaccine (FluMist®)
4 March 2026
NationalProfessional activitiesVaccinationPractice support, tips and tools
Learn more
Cover for partnered charting and prescribing activities
24 November 2025
NationalProfessional activitiesPharmacist prescribing
Learn more
Join PDL
Log in

It's time to renew your PDL membership for the year ahead.

Renew your PDL membership now and take a moment to review your Practice Profile, as updates have been made to our areas of practice. You can log in to the member portal using your email address or mobile number. 

Renew Now